RIGOL Details Updated Board Composition and Committee Leadership

Bulletin Express
Aug 07

RIGOL Technologies Co., Ltd. released an announcement dated 7 August 2026 confirming the current make-up of its Board of Directors and the leadership of its five specialised committees.

The Board now consists of seven members, structured as four executive directors and three independent non-executive directors:

• Executive Directors: – Dr. Wang Yue, Chairman – Mr. Wang Ning, Chief Executive Officer – Dr. Sun Ningxiao, Co-Chief Executive Officer – Mr. Cheng Jianchuan

• Independent Non-Executive Directors: – Dr. Qin Ce – Dr. Liu Liansheng – Ms. Xu Xu

Committee responsibilities have been assigned as follows:

1. Audit Committee • Chair: Ms. Xu Xu • Members: Dr. Qin Ce, Dr. Liu Liansheng

2. Remuneration and Evaluation Committee • Chair: Dr. Liu Liansheng • Members: Dr. Wang Yue, Mr. Cheng Jianchuan

3. Nomination Committee • Chair: Dr. Qin Ce • Members: Dr. Liu Liansheng, Ms. Xu Xu

4. Strategy Committee • Chair: Mr. Wang Ning • Members: Dr. Wang Yue, Dr. Qin Ce

5. Environmental, Social and Governance Committee • Chair: Ms. Xu Xu • Members: Mr. Cheng Jianchuan, Dr. Qin Ce, Dr. Liu Liansheng

The updated structure underscores RIGOL’s adherence to corporate governance best practices, with independent non-executive directors chairing three of the five committees and occupying 43% of total Board seats.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10